Available Programs

Moving Toward a Cure for More Patients With Hodgkin Lymphoma: Expert Guidance and Case Discussions

Attend this live symposium in San Diego to learn how experts are applying novel strategies in treating Hodgkin lymphoma! Interact with the experts as they discuss best practices and emerging clinical data in an engaging, case-based format.

Friday Satellite Symposium preceding the 60th ASH Annual Meeting & Exposition.

1 upcoming events, beginning 11/30/2018More Information

Moving Toward Precision Therapy for Patients With AML: Clinical Challenges and Future Directions

Engage with your peers and the experts during this interactive CME-certified live symposium! Learn to apply the latest practice-changing developments in your clinical care of patients with acute myeloid leukemia.

Friday Satellite Symposium preceding the 60th ASH Annual Meeting & Exposition.

1 upcoming events, beginning 11/30/2018More Information

New Strategies for Multiple Myeloma Care: Next Steps for the Future

Join us for this year’s International Myeloma Foundation and Clinical Care Options cosponsored symposium, where an esteemed panel of international experts will offer their perspectives on practice-changing data and optimal management of patients with myeloma.

Interact with the experts as they debate current clinical questions as well as the immediate and future implications for therapeutic decision making based on  emerging clinical data.

Friday Satellite Symposium preceding the 60th ASH Annual Meeting & Exposition.

1 upcoming events, beginning 11/30/2018More Information

New Advances, Clinical Opportunities, and Current Challenges in Treating Adults With Ph-Negative ALL

Gain expert perspective on recent changes that are improving care for patients with acute lymphoblastic leukemia. Representative cases and slides will emphasize key data and provide the rationale for treatment decisions. 

Join us to fully interact, text, and contribute to the content and outcome of this event!

Friday Satellite Symposium preceding the 60th ASH Annual Meeting & Exposition.

1 upcoming events, beginning 11/30/2018More Information

HR+/HER2- Metastatic Breast Cancer: Current Practice, Open Questions, and Future Directions

Join us for this interactive symposium, where experts will discuss the evolving treatment paradigm in HR-positive/HER2-negative MBC, including the subtleties of optimal clinical application of CDK4/6 inhibitor therapy, the evolving role of PI3K pathway blockade, and how new strategies may affect management of these patients in the near future.

Held in conjunction with SABCS® 2018

1 upcoming events, beginning 12/05/2018More Information

PARP Inhibitors in Breast Cancer: Expert Perspectives on Clinical Application and Genetic Testing

Join us for this live interactive CME/CE/CPE-certified symposium at SABCS 2018! Expert faculty will provide their perspectives on PARP inhibitors for breast cancer, including insights into their mechanism of action and unique clinical characteristics, integration into current clinical management strategies based on available supporting evidence, and emerging approaches to enhance the utility of these agents for patients with breast cancer.

Held in conjunction with SABCS® 2018

2 upcoming events, beginning 12/06/2018More Information

Assessing RET-Altered Tumors: An Increasingly Important Target for Personalized Oncology Care

Learn about the latest clinical data on selective RET inhibitors along with practical guidance to facilitate the detection of RET alterations from leading pathology experts in this dynamic, CME-certified satellite symposium at CAP 2018! Expert faculty will lead discussions and answer your questions on the methodology and testing strategies for RET fusions and mutations.

Sign up today! Registration is complimentary.

This program is not an official event of CAP18 and is not sponsored, endorsed, or accredited by the CAP or any of the cosponsoring organizations of CAP18.

There are no upcoming events, please check back soon.

Checkpoint Inhibition in Stage III NSCLC: Current Practice, Open Questions, and Future Directions

Designed to improve clinician performance and patient outcomes, this interactive symposium will investigate the subtleties and challenges of optimal clinical application of checkpoint inhibition for treating unresectable stage III NSCLC. Gain expert insights on when and how to use immune checkpoint inhibitors in this earlier disease setting, with an opportunity to submit your most pressing questions.

Reserve your spot now!

The "Checkpoint Inhibition in Stage III NSCLC: Current Practice, Open Questions, and Future Directions,” content and views expressed therein are those of Clinical Care Options, LLC and not of SITC.

There are no upcoming events, please check back soon.

Immune Checkpoint Inhibitors in the Treatment of Stage III NSCLC: A Primer for Managed Care Pharmacy

Register today for this dynamic, clinic-focused symposium on the pharmacist’s role in optimizing care of patients with unresectable stage III NSCLC through checkpoint inhibitor–based strategies! Bring your challenging case questions and get answers from both pharmacy and oncology experts.

Held in conjunction with AMCP Nexus 2018.

There are no upcoming events, please check back soon.

Tailoring Treatment of EGFR-Mutated NSCLC: Pharmacy Perspectives to Improve Patient Care

Join us for this interactive symposium where pharmacy and oncology experts Val R. Adams, PharmD, FCCP, BCOP; Edward S. Kim, MD, FACP; and Philip Schwieterman, PharmD, MHA, provide their perspectives on the role of EGFR-targeted therapies in the management of patients with advanced EGFR-mutated NSCLC, including insights into the latest first-line and second-line clinical data and how pharmacists can safely and effectively apply these new practice-changing data into care plans for their patients.

Held in conjunction with AMCP Nexus 2018.

There are no upcoming events, please check back soon.

Expert Perspectives on Therapeutic Advances to Improve Clinical Outcomes of Veterans With NSCLC

Acquire expert insight on the optimal care for your VHA patients with NSCLC in this complimentary, interactive 1-hour live meeting.

2 upcoming events, beginning 11/29/2018More Information

Navigating the Evolving Treatment Landscape in Pancreatic Cancer: Expert Guidance for Clinicians

Gain expert guidance on the latest treatment of newly diagnosed and relapsed/refractory advanced pancreatic cancer in this 1-hour interactive meeting. Afterward, an associated downloadable slideset will be available on the CCO Web site to enhance the information presented at the live meetings.

4 upcoming events, beginning 12/06/2018More Information

Expert Treatment Recommendations on New Clinical Developments in Frontline Follicular Lymphoma

In this series of 1-hour CME-certified live meetings, expert faculty provide guidance on the latest evidence-based approaches for treating newly diagnosed follicular lymphoma. Afterward, use CCO’s online decision support tool for frontline follicular lymphoma and download the associated slideset and Clinical Resources to enhance the information presented at the live meeting.

3 upcoming events, beginning 12/11/2018More Information

Expert Perspectives on CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer

Register now for this complimentary, live 1-hour CME-certified meeting featuring expert discussion of cases and the latest data on leveraging CDK4/6 inhibitors in hormone receptor–positive, HER2-negative breast cancer.

Afterward, use CCO’s online Interactive Decision Support Tool for metastatic breast cancer (coming soon) to gain expert advice customized to your own challenging cases and download the associated slideset based on the content of the live meetings.

4 upcoming events, beginning 12/12/2018More Information

Optimal Use of BTK Inhibitors in B-Cell Malignancies: Perspectives for the Healthcare Team

Interact with peers while gaining expert insight on the optimal treatment of B-cell malignancies with BTK inhibitors in this interactive, case-based 1-hour live meeting, highlighting the latest clinical data as well as expert treatment options from CCO’s online treatment decision tool. After the meeting, download the associated slideset for use in your clinic.

2 upcoming events, beginning 12/14/2018More Information

New Treatments and Insights in MM: Equipping Nurses to Manage a Complex and Rapidly Evolving Disease

Interact with peers while gaining expert insight on optimal treatment of multiple myeloma in this interactive 1-hour live meeting, and then download a summary resource guide and associated slideset for use in your clinic.

2 upcoming events, beginning 01/08/2019More Information

Understanding the Latest Therapeutic Advances in Multiple Myeloma

Join us for a live CME/CE-certified event to hear from experts on the latest data and therapeutic options for patients with myeloma.

4 upcoming events, beginning 02/05/2019More Information

Advances in Pancreatic Cancer: Guidance to Improve the Care of Veterans

Interact with peers while gaining expert insight on optimal treatment of pancreatic cancer in this interactive 1-hour live meeting, and then download a summary resource guide and associated slideset for use in your clinic.

There are no upcoming events, please check back soon.

New Adjuvant Treatment Strategies for Early-Stage HER2-Positive Breast Cancer

Register now for this complimentary, live 1-hour CE-certified meeting where you can gain expert guidance on the optimal nursing care of patients with HER2-positive early breast cancer. Afterward, utilize CCO’s online early breast cancer decision support tool (coming soon), view a CE-certified Webcast, and download the associated slideset and pocket guides to enhance the information presented at the live meetings.

There are no upcoming events, please check back soon.

Practical Guidance on Immune Checkpoint Inhibitors in NSCLC: CCO ClinicalImpact Live

Register now for this complimentary, live 1-hour CME/CE/CPE-certified meeting where you can gain expert guidance on the optimal application of immune checkpoint inhibitors in treating non-small-cell lung cancer and interact with faculty. Afterward, use CCO’s online NSCLC decision support tools and download the associated slideset and NSCLC Clinical Resource to enhance the information presented at the live meetings.

There are no upcoming events, please check back soon.